Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT00135226
PHASE4

ASCEND: A Study of Cardiovascular Events iN Diabetes

Sponsor: University of Oxford

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether 100mg daily aspirin versus placebo and/or supplementation with 1 gram daily omega-3 fatty acids or placebo prevents "serious vascular events" (i.e. non-fatal heart attack, non-fatal stroke or transient ischaemic attack, or death from vascular causes) in patients with diabetes who are not known to have occlusive arterial disease and to assess the effects on serious bleeding or other adverse events.

Official title: A Study of Cardiovascular Events iN Diabetes - A Randomized 2x2 Factorial Study of Aspirin Versus Placebo, and of Omega-3 Fatty Acid Supplementation Versus Placebo, for Primary Prevention of Cardiovascular Events in People With Diabetes

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

15480

Start Date

2005-03

Completion Date

2037-07-31

Last Updated

2025-05-28

Healthy Volunteers

No

Interventions

DRUG

Aspirin

DRUG

Omega-3 Ethyl Esters

DRUG

Placebo Aspirin

DRUG

Placebo Omega-3 Ethyl Esters

Locations (1)

Clinical Trial Service Unit, NDPH, University of Oxford

Oxford, United Kingdom